Rescheduling Breast Reconstruction Post-Pandemic Will Present 'Interesting Logistical Puzzle' For Some

Video

As patients begin to look at what’s to come when lockdown measures in place are relaxed a new logistical puzzle will pop for some.

Patients seeking reconstructive breast surgery after surgical centers are allowed to reopen after COVID-19 should trust their regional health systems to triage cases in a responsible fashion and expect them to be handled on a priority basis, according to one expert.

As the novel coronavirus has spread across the world, all elective surgeries, including breast reconstruction, have been delayed. Many women with breast cancer may wonder what might happen once plastic surgeons are given the greenlight to reopen and schedule reconstructive surgeries again.

In an interview with CURE®, Dr. Jonathan Bank, a board-certified plastic surgeon at New York Breast Reconstruction and Aesthetic (NYBRA) Plastic Surgery, discussed the planning that will go on to ensure there is very limited disruption to rescheduling appointments, as well as certain instances where challenges might ensue.

“… Trust your regional health system to triage the cases in a responsible fashion,” Bank, who specializes in breast reconstruction after cancer, said. “There's going to be a combination of administrators, but also professional medical staff that, in consultation with doctors that are managing the specific cases, will come to an understanding. I'm sure there is going to be extensive planning and just dealing with things on a priority basis.”

Bank explained that most hospitals and surgical centers allot surgeons a certain amount of time either per week or per month to perform their scheduled procedures. In some instances, such as with NYBRA Plastic Surgery, surgeons will operate out of several sites to coordinate surgeries and allow flexibility to see more patients. However, Bank noted that not everyone operates out of several sites which could be tricky when trying to reschedule with patients.

“It’s going to be an interesting logistical puzzle to manage, but in this day and age we have to do what is good for all of us and see what happens when we do and when we don't, so I think this is just an extension to what the world is experiencing,” he said.

Related Videos
Image of Kristen Dahlgren at Extraordinary Healer.
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.